White-Label Telehealth Pricing Models: Setup, Per-Patient, Revenue Share

White-label telehealth pricing models usually combine one-time implementation charges with recurring software, usage, clinical, payment, support, and third-party service costs. The right structure depends less on a headline price than on expected volume, service scope, payer mix, state-by-state operations, and whether the vendor’s compensation is connected to medical activity.

What does a white-label telehealth platform cost?

There is no federally prescribed commercial price for a white-label telehealth platform. Vendors may charge a setup fee, monthly or annual subscription, per-patient or per-encounter fee, transaction fee, revenue share, or a combination. The approved research does not establish reliable market-wide dollar ranges, so operators should not treat an unverified “average” as a budgeting fact.

A useful budget separates costs into these categories:

The most important planning step is to avoid combining technology costs with clinical judgment or clinical labor. A business brand can coordinate software and operations, but licensed clinicians must independently handle professional medical decisions within applicable requirements.

How do the main white-label telehealth pricing models work?

The four structures below are useful starting points for a vendor comparison.

1. Setup fee plus recurring subscription

A setup-plus-subscription model charges an implementation amount first, then a monthly or annual platform fee. It often fits an operator that needs branded workflows, integrations, domain configuration, analytics, or a more predictable operating budget.

This model can become easier to forecast as volume grows because the core technology charge may not rise with every encounter. The tradeoff is that the contract may include minimum terms, renewal increases, limits on brands or locations, or separate charges for support, data export, sandbox access, testing, and regulatory or API changes.

Ask the vendor to identify each item included in implementation rather than accepting “custom setup” as a complete description. A project that excludes integration work or migration can have a very different total cost from one that includes it.

2. Per-patient or per-encounter pricing

Per-patient pricing charges for a defined patient, appointment, completed encounter, active member, or clinical episode. It can suit a pilot, seasonal service, or early-stage business with uncertain demand because the initial commitment may be lower.

The definition of “patient” is the commercial issue to resolve first. A registered account, completed intake, scheduled visit, completed visit, paying patient, and active member are not necessarily the same event. The agreement should also address canceled visits, no-shows, duplicate accounts, refunds, abandoned intakes, support messages, follow-ups, and asynchronous reviews.

Request volume tiers, a fee cap, and a worked example using your expected monthly volume. A per-patient quote without a precise billing trigger is not enough to compare vendors.

3. Subscription plus usage or transaction fees

A hybrid model combines a recurring platform charge with fees for selected usage, transactions, messages, encounters, integrations, or administrative services. It may provide more flexibility than a fully fixed subscription, but it also creates more opportunities for add-on costs.

For a meaningful comparison, build a monthly scenario with low, expected, and high utilization. Include failed appointments, refunds, chargebacks, support tickets, and any services that may be counted separately. The goal is not to predict revenue or margins; it is to expose how the invoice behaves when operations change.

4. Revenue share

A revenue-share model pays the vendor a percentage of collections, gross sales, membership revenue, or another defined base. It may reduce upfront cash requirements when the vendor provides substantial nonclinical infrastructure, marketing, billing, or administrative support.

Revenue share is not automatically unlawful or automatically compliant. It deserves transaction-specific legal review when compensation is tied to professional medical services, referrals, prescriptions, laboratory services, tests, orders, or reimbursable claims. State fee-splitting, corporate-practice-of-medicine, professional-entity, and related rules can be fact-specific.

The contract should define refunds, taxes, insurance adjustments, chargebacks, bad debt, denied claims, and the timing of calculation. It should also state whether the vendor can influence clinical utilization, prescribing, referrals, or patient steering. A percentage may look modest at low volume but become expensive as collections increase, so model the arrangement across multiple scenarios.

Which pricing model fits your expected volume?

Use this sequence before requesting final proposals:

1. 1Define the service scope. List technology, implementation, clinical labor, patient support, billing, marketing, payment processing, pharmacy, laboratory, and other third-party functions separately.
2. 2Estimate three volume cases. Prepare pilot, expected, and high-volume assumptions. Do not use a single forecast to evaluate a variable fee.
3. 3Classify the revenue source. Identify whether the program is cash-pay, commercial insurance, Medicare, Medicaid, or mixed. If insurance is involved, ask whether claims, coding, enrollment, denials, and collections are included.
4. 4Test the billing trigger. Determine whether a charge follows registration, activation, scheduling, completion, payment, or another event.
5. 5Review regulatory dependencies. Confirm which party monitors changes affecting privacy, telehealth, payer rules, prescribing, and state operations.
6. 6Compare exit economics. Ask about minimum terms, renewal increases, data export, termination assistance, unpaid balances, and post-termination access.

Which line items vary most by state and program?

Technology pricing may be national, but the operating scope is not. State and program review can affect provider authorization, professional-entity structure, corporate-practice considerations, fee-splitting analysis, informed consent, prescribing, privacy, billing, refunds, marketing, and pharmacy or laboratory relationships. The research packet does not establish a universal state rule, so a national quote should not be treated as a state-by-state compliance determination.

Clinical scope also changes the commercial picture. A software-only platform has a different contract boundary from an arrangement that includes clinicians, billing, patient support, marketing, pharmacy coordination, or laboratory coordination. The business should document who owns the patient relationship, who controls records, and who makes clinical decisions.

HIPAA status depends on functions, not on the phrase “white label.” HHS explains that a vendor creating, receiving, maintaining, or transmitting protected health information on behalf of a covered entity may be a business associate and may need a written business associate agreement. A telecommunications conduit may be treated differently when access is transient, but a vendor performing services involving protected health information generally requires closer analysis.

A consumer health application that is not a HIPAA covered entity or business associate is not automatically free from health-data obligations. The FTC’s Health Breach Notification Rule can apply to certain health apps and related entities outside HIPAA. Contracts should assign data control, breach response, notices, deletion, return, and subcontractor responsibilities.

If Medicare telehealth is part of the plan, CMS updates its telehealth services and payment information by calendar year. CMS’s 2026 materials identify a $31.85 Medicare telehealth originating-site facility fee. That fact does not establish what a platform should charge or what a program will collect. It does mean the contract should specify whether any percentage is based on gross patient payments, allowed amounts, payer deposits, copayments, deductibles, refund-adjusted revenue, or another amount.

For controlled-substance telemedicine, DEA announced a temporary extension of specified flexibilities through December 31, 2026, subject to conditions and other federal and state requirements. A platform supporting that workflow should assign responsibility for monitoring changes and paying for resulting credentialing, documentation, workflow, or technical changes.

How should recurring telehealth charges be disclosed and canceled?

Recurring-plan terms should be presented clearly before billing information is collected, with express informed consent before a recurring charge and a simple way to stop future recurring charges. The Restore Online Shoppers’ Confidence Act establishes these requirements for online sellers of recurring plans. The FTC’s 2024 “click-to-cancel” amendments to its Negative Option Rule are not currently in force: the U.S. Court of Appeals for the Eighth Circuit vacated them on July 8, 2025, and the FTC’s March 11, 2026 advance notice of proposed rulemaking is only a proposal.

For pricing evaluation, ask who owns subscription disclosures, consent records, cancellation workflows, refunds, and customer support. Do not describe ordinary checkout language as FDA- or FTC-approved, and do not assume a platform’s tools alone resolve applicable state or federal obligations.

Operators adding a specialty service can also use a broader telehealth launch timeline to map dependencies before comparing quotes.

What should a white-label telehealth contract disclose?

Use this checklist during vendor review:

• Implementation deliverables, milestones, acceptance criteria, and change-order rules
• Included integrations, migration, analytics, testing, support, and custom workflows
• Subscription term, renewal increases, minimums, seats, locations, brands, and records
• Exact definition of a billable patient, encounter, transaction, or active member
• Treatment of no-shows, cancellations, refunds, chargebacks, duplicate accounts, and abandoned intakes
• Whether provider compensation and clinical services are outside the platform fee
• Revenue-share calculation, audit rights, payment timing, and excluded amounts
• Any payment connected to prescriptions, referrals, tests, laboratory services, or medical orders
• HIPAA role, BAA obligations, subcontractors, security incidents, and breach costs
• Data ownership, export format, deletion, return, and post-termination access
• Responsibility for changes involving CMS, DEA, HHS, FTC, or state requirements
• Marketing, patient-support, billing, pharmacy, laboratory, and fulfillment responsibilities
• Recurring-plan disclosures, consent records, cancellation tools, refunds, and support ownership

MDLaunchr is the brand behind WhiteLabelClinic.com, one infrastructure option in this category. It is designed to help qualified businesses evaluate and coordinate technology, operational, compliance, clinical-network, and fulfillment relationships; it is not a treating clinician, law firm, regulator, or guarantor of approval. See pricing to continue the commercial evaluation with scope and assumptions clearly defined.

Related reading: How a Dermatology Practice Can Add a Telehealth Hair Restoration Program.